Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Shapiro

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 26, 2017
Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulantsEllen M Uppuluri, Kelly R Burke, Christina Mactal Haaf, et al.
The Annals of Pharmacotherapy|May 19, 2016
Upper-Extremity Deep-Vein Thrombosis: A Retrospective Cohort Evaluation of Thrombotic Risk Factors at a University Teaching Hospital Antithrombosis ClinicRebecca H Stone, Adam P Bress, Edith A Nutescu, et al.
Pharmacotherapy|September 20, 2011
Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experienceNancy L Shapiro, Michelle A Kominiarek, Edith A Nutescu, et al.
Blood Cells, Molecules & Diseases|December 28, 2010
Pharmacogenomics of warfarin dose requirements in HispanicsLarisa H Cavallari, Kathryn M Momary, Shitalben R Patel, et al.
Journal of Thrombosis and Thrombolysis|June 20, 2008
Predictors of unstable anticoagulation in African AmericansLarisa H Cavallari, Jonathan L Aston, Kathryn M Momary, et al.
Pharmacogenomics|November 24, 2007
Factors influencing warfarin dose requirements in African-AmericansKathryn M Momary, Nancy L Shapiro, Marlos Ag Viana, et al.
Pharmacotherapy|September 20, 2011
Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patientsLarisa H Cavallari, Christopher Butler, Taimour Y Langaee, et al.
Heart & Lung : the Journal of Critical Care|June 8, 2023
Comparison of thrombotic and clinical outcomes in SARS-CoV-2-pneumonia versus other viral pneumonia in an urban academic medical centerRachel Goldberg, William Ye, Kevin Johns, et al.
Pharmacotherapy|April 11, 2016
Recommendations for Aligning PGY2 Pharmacy Residency Training and Pharmacy Specialist Board Certification, Todd D Sorensen, Nancy L Shapiro, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 25, 2009
Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for strokeKathryn M Momary, Nancy L Shapiro, Larry D Brace, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 26, 2017
Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulantsEllen M Uppuluri, Kelly R Burke, Christina Mactal Haaf, et al.
The Annals of Pharmacotherapy|May 19, 2016
Upper-Extremity Deep-Vein Thrombosis: A Retrospective Cohort Evaluation of Thrombotic Risk Factors at a University Teaching Hospital Antithrombosis ClinicRebecca H Stone, Adam P Bress, Edith A Nutescu, et al.
Pharmacotherapy|September 20, 2011
Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experienceNancy L Shapiro, Michelle A Kominiarek, Edith A Nutescu, et al.
Blood Cells, Molecules & Diseases|December 28, 2010
Pharmacogenomics of warfarin dose requirements in HispanicsLarisa H Cavallari, Kathryn M Momary, Shitalben R Patel, et al.
Journal of Thrombosis and Thrombolysis|June 20, 2008
Predictors of unstable anticoagulation in African AmericansLarisa H Cavallari, Jonathan L Aston, Kathryn M Momary, et al.
Pharmacogenomics|November 24, 2007
Factors influencing warfarin dose requirements in African-AmericansKathryn M Momary, Nancy L Shapiro, Marlos Ag Viana, et al.
Pharmacotherapy|September 20, 2011
Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patientsLarisa H Cavallari, Christopher Butler, Taimour Y Langaee, et al.
Heart & Lung : the Journal of Critical Care|June 8, 2023
Comparison of thrombotic and clinical outcomes in SARS-CoV-2-pneumonia versus other viral pneumonia in an urban academic medical centerRachel Goldberg, William Ye, Kevin Johns, et al.
Pharmacotherapy|April 11, 2016
Recommendations for Aligning PGY2 Pharmacy Residency Training and Pharmacy Specialist Board Certification, Todd D Sorensen, Nancy L Shapiro, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 25, 2009
Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for strokeKathryn M Momary, Nancy L Shapiro, Larry D Brace, et al.
Pageof 4